{"nctId":"NCT00056472","briefTitle":"Study of Pharmacotherapy of Psychotic Depression","startDateStruct":{"date":"2003-01"},"conditions":["Major Depressive Disorder With Psychotic Features"],"count":259,"armGroups":[{"label":"olanzapine/sertraline combination","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Olanzapine","Drug: Sertraline"]},{"label":"olanzapine plus placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Olanzapine","Other: placebo"]}],"interventions":[{"name":"Olanzapine","otherNames":["Zyprexa"]},{"name":"Sertraline","otherNames":["Zoloft"]},{"name":"placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Major depressive disorder, single or recurrent, with psychotic features\n\nExclusion Criteria:\n\n* History of substance abuse or dependence within the 3 months prior to enrollment\n* Acute or unstable medical illness\n* Diagnosis of schizophrenia or other psychotic disorders\n* Pregnant\n* Intolerance to SSRIs or olanzapine","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Remission of Depression Hamilton Depression Scale (Ham-D) and Psychosis Schedule for Affective Disorders in Schizophrenia - Delusional Item (SADS) During the Course of the Trial","description":"Remission was defined as scores on Ham-D of less than 10 at two consecutive assessments and the absence of delusions (measured as SADS delusional item scores of 1) at the second assessment of the two-assessment remission of depression interval.\n\nScores on Ham-D range from 0 to 52 with higher scores indicating more severe depression. Scores on SADS range from 1 to 7 with higher scores indicating the delusions(s) more adversely effect the subject's behavior.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"54","spread":null},{"groupId":"OG001","value":"31","spread":null}]}]}]},{"type":"SECONDARY","title":"Scores on CGI-S Compared to Baseline Over the Course of the Trial","description":"A measure of overall symptom severity, the Clinical Global Impressions, Severity of Illness Scale (CGI-S). It is a seven point scale with a one indicating not at all ill, and seven indicating the most extremely ill. This rating was done each week after baseline by the PI at each site after visiting with the patient.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.24","spread":".07"},{"groupId":"OG001","value":"2.48","spread":".07"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Mean Score Hamilton Depression Rating Scale (Ham-D) Over the Course of the Trial From Week to Week.","description":"The Ham-D measures depression severity. Scores on Ham-D range from 0 to 52 with higher scores indicating more severe depression.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13.27","spread":".61"},{"groupId":"OG001","value":"16.63","spread":".61"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":9,"n":129},"commonTop":["weight gain","fall","sleepiness/sedation","increased lab values","reduced sleep"]}}}